ArticleOncotarget2016

IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.

Ciara H O'Flanagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.